组织外泌体蛋白质组学鉴定食管癌症有前景的诊断生物标志物
核心信息
- 论文英文标题: Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer
- 期刊: Elife
- 发表年份: 2023
- DOI: 10.7554/eLife.95305
- PMID/PMCID: 38116754; PMC10732569
研究概览
This publication focuses on 食管癌, with the study topic reflected by the title: "Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer". Echo Biotech contributed EV isolation and purification, EV proteomics.
Echo Biotech 角色
组织外泌体分离及蛋白质组
关联平台: Exoomics®
关联服务与能力: Tissue EV Isolation & Purification, EV Proteomics
关联产品或试剂: 无明确产品引用
参考文献
原始论文: Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer Elife. 2023. DOI: 10.7554/eLife.95305. PMID/PMCID: 38116754; PMC10732569.